About this page
ZVRA — Zevra Therapeutics
Why Zevra Therapeutics (ZVRA) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Zevra Therapeutics (ZVRA) fell 3.42% at the close. Where it came from: Market (SPY) -3.78%, Biotech & Genomics +1.28%, Pharmaceuticals +0.09%, Biotechnology -0.07%, Factors (6) -0.39%, Unique to ZVRA -0.55%. The market drove most of ZVRA's decline.
Fell with the market: chipmakers led it lower on Anthropic headlines (Yahoo). The stories that moved the market.
Zevra Therapeutics (ZVRA) last reported earnings on Tuesday, November 3, 2026, after the close (SEC 8-K); the next session, Wednesday, November 4, 2026, ZVRA rose 8.87% at the close. Its next report is estimated for about Monday, February 8, 2027 (between February 4 and February 12), after the close, from its own rhythm across 10 reports; not yet announced. The earnings calendar.
Explained moves for ZVRA:
- Monday, November 16, 2026: Zevra rose 1.9% after Guggenheim cut its price target following the EMA's confirmed refusal of arimoclomol (streetinsider.com)
Each explained move has its own page: Monday, November 16, 2026 · Friday, November 13, 2026.
Only on this page: ZVRA's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind each of its 2 explained moves, with sources.
Explore daily moves on this page shows where ZVRA's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.